Truist Financial Increases AdaptHealth (NASDAQ:AHCO) Price Target to $14.00

AdaptHealth (NASDAQ:AHCO - Free Report) had its target price upped by Truist Financial from $12.00 to $14.00 in a research report released on Wednesday morning,Benzinga reports. Truist Financial currently has a buy rating on the stock.

Other equities analysts have also issued research reports about the company. Canaccord Genuity Group lowered their price objective on AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a research note on Wednesday, November 6th. Royal Bank of Canada reduced their target price on AdaptHealth from $13.00 to $11.00 and set an "outperform" rating on the stock in a report on Tuesday, November 19th. Robert W. Baird reduced their target price on AdaptHealth from $16.00 to $14.00 and set an "outperform" rating on the stock in a report on Wednesday, November 6th. Finally, UBS Group reduced their target price on AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a report on Thursday, February 13th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $13.80.

AdaptHealth Price Performance

AdaptHealth stock traded up $0.29 during mid-day trading on Wednesday, reaching $11.38. 1,758,793 shares of the company were exchanged, compared to its average volume of 1,099,020. The company has a fifty day simple moving average of $9.92 and a 200-day simple moving average of $10.23. AdaptHealth has a 12 month low of $8.35 and a 12 month high of $11.90. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The firm has a market cap of $1.53 billion, a PE ratio of -6.90, a PEG ratio of 1.08 and a beta of 1.12.

Institutional Investors Weigh In On AdaptHealth

Hedge funds have recently modified their holdings of the company. Assetmark Inc. acquired a new stake in shares of AdaptHealth during the 4th quarter valued at $28,000. Blue Trust Inc. raised its position in AdaptHealth by 24.1% during the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company's stock worth $55,000 after purchasing an additional 1,115 shares during the last quarter. Quarry LP raised its position in AdaptHealth by 4,596.9% during the 3rd quarter. Quarry LP now owns 5,965 shares of the company's stock worth $67,000 after purchasing an additional 5,838 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its position in AdaptHealth by 15.4% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company's stock worth $121,000 after purchasing an additional 1,690 shares during the last quarter. Finally, CIBC Asset Management Inc bought a new position in AdaptHealth during the 3rd quarter worth $122,000. Institutional investors and hedge funds own 82.67% of the company's stock.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.